Survey for pharmacy professional organizations and other stakeholders to determine policies and practices around pharmacy-delivered vaccination in Latin America.
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: SOLER, Maria (FIDEC, Miami, United States)
- Co-author(s): Daniel Stamboulian:,FIDEC,Miami,United States|Lujan Soler:,FIDEC,Miami,United States|Pablo Copertari:,FIDEC,Miami,United States|Ana Paula Cordero:,FIDEC,Miami,United States|Hebe Vazquez:,FIDEC,Miami,United States|Pilar Valanzasca:,FIDEC,Miami,United States|Homero Monsanto:Latin America Health Outcomes Research,Merck Sharpe & Dohme,Carolina,Puerto Rico|John D Grabenstein:Merck Vaccines, West Point,Merck Co. & Inc.,PA,United States|Kelly D Johnson:Center for Observational and Real-World Evidence, Vaccines, Kenilworth,Merck Co. & Inc.,NJ,United States
Vaccines are one of the most successful and cost-effective public health interventions, preventing between 2 and 3 million deaths annually worldwide. Despite the availability of effective vaccines, adult vaccination rates remain low in most countries. Pharmacists have demonstrated a critical role in vaccine delivery in several countries. It is.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.